Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$536.17 USD
+6.24 (1.18%)
Updated May 7, 2024 04:00 PM ET
After-Market: $536.09 -0.08 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
ELV 536.17 +6.24(1.18%)
Will ELV be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ELV
Is Elevance Health (ELV) a Buy as Wall Street Analysts Look Optimistic?
If You Invested $1000 in Elevance Health a Decade Ago, This is How Much It'd Be Worth Now
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
HCA Healthcare's (HCA) Q1 Earnings Beat on Rising Admissions
Here's Why Elevance Health (ELV) is a Strong Momentum Stock
Here's Why Elevance Health (ELV) is a Strong Momentum Stock
Other News for ELV
New house bill to extend COVID-era telehealth flexibilities
CVS Health: Show-Me Story Is Dead For The Near Term
U.S. expands federal health coverage for DACA immigrants
How To YieldBoost Elevance Health From 1.2% To 5.8% Using Options
CVS Health drops as medical cost trends prompt guidance cut